2017
DOI: 10.5455/ijmsph.2017.0823622092017
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of non-albicans candidemia in a tertiary care hospital in Northeast India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

4
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 19 publications
4
1
0
Order By: Relevance
“…In our study, although NAC isolates were more resistant to antifungals than was C. albicans, the difference was statistically significant only for amphotericin B (P = .03). Similar findings have been reported in another study from northeastern India by Sabhapandit D et al 23 Resistance to fluconazole has been observed in 38% of isolates, with NACs being more resistant than C. albicans (36% vs 2%). This finding is of concern because alternative drugs like echinocandins or amphotericin B are more expensive.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In our study, although NAC isolates were more resistant to antifungals than was C. albicans, the difference was statistically significant only for amphotericin B (P = .03). Similar findings have been reported in another study from northeastern India by Sabhapandit D et al 23 Resistance to fluconazole has been observed in 38% of isolates, with NACs being more resistant than C. albicans (36% vs 2%). This finding is of concern because alternative drugs like echinocandins or amphotericin B are more expensive.…”
Section: Discussionsupporting
confidence: 90%
“…Similar rates of resistance have been reported in other contemporary studies as well. 23,26 Resistance to amphotericin B was significantly high in NAC isolates in our study.…”
Section: Discussionmentioning
confidence: 56%
“…In concordance with other studies across the country, we observed an overall higher invitro resistance in NAC isolates compared to C. albicans (7,17,18). Azoles including fluconazole showed 100% susceptibility against C. albicans thus implying it can be used as drug of choice in our ICU settings.…”
Section: Discussionsupporting
confidence: 90%
“…Regarding NAC sensitivity to fluconazole, similar findings were published in a study from India 27 . The increased resistance to fluconazole is of serious concern as it is the most used azole for superficial and deep candidiasis 28 .…”
Section: Discussionsupporting
confidence: 85%